We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
+26.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.68T
AUM Growth
+$637B
(+16%)
Cap. Flow
+$33.9B
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
32.56%
Holding
4,163
New
102
Increased
2,573
Reduced
1,196
Closed
71
Avg Time Held
1
quarter
Top 10 Avg Time Held
0.9
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HONA
Honeywell Aerospace
HONA
|
+$4.57B |
| 2 |
SPCX
SpaceX
SPCX
|
+$4.51B |
| 3 |
Marvell Technology
MRVL
|
+$3.77B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.69B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$4.59B |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$1.69B |
| 3 |
Salesforce
CRM
|
+$1.28B |
| 4 |
JPMorgan Chase
JPM
|
+$1.15B |
| 5 |
HOLX
Hologic
HOLX
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.14% |
| 2 | Financials | 12.19% |
| 3 | Industrials | 9.6% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Discretionary | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2351
Lexicon Pharmaceuticals
LXRX
$810M
| $23.8M | ﹤0.01% |
9,901,208
+382,041
| +4% | +$744K |
2026 Q1
1 quarter
|
|
2352
Compass Diversified
CODI
$822M
| $23.7M | ﹤0.01% |
2,227,358
+30,435
| +1% | +$332K |
2026 Q1
1 quarter
|
|
2353
Gilat Satellite Networks
GILT
$773M
| $23.7M | ﹤0.01% |
1,776,853
-44,315
| -2% | -$726K |
2026 Q1
1 quarter
|
|
|
AGNT
2354
AGNT Inc
AGNT
$610M
| $23.7M | ﹤0.01% |
4,377,613
+165,628
| +4% | +$913K |
2026 Q1
1 quarter
|
|
2355
Mesa Laboratories
MLAB
$742M
| $23.6M | ﹤0.01% |
237,457
+4,814
| +2% | +$485K |
2026 Q1
1 quarter
|
|
2356
Copel
ELPC
$9.55B
| $23.6M | ﹤0.01% |
2,027,683
-41,934
| -2% | -$512K |
2026 Q1
1 quarter
|
|
2357
Hingham Institution for Saving
HIFS
$632M
| $23.6M | ﹤0.01% |
76,867
+2,149
| +3% | +$618K |
2026 Q1
1 quarter
|
|
2358
Sprinklr
CXM
$1.21B
| $23.5M | ﹤0.01% |
4,557,164
-781,153
| -15% | -$4.15M |
2026 Q1
1 quarter
|
|
|
BDN
2359
Brandywine Realty Trust
BDN
$479M
| $23.4M | ﹤0.01% |
7,384,527
-12,111
| -0.2% | -$36.4K |
2026 Q1
1 quarter
|
|
2360
Wabash National
WNC
$572M
| $23.4M | ﹤0.01% |
1,732,718
-54,181
| -3% | -$481K |
2026 Q1
1 quarter
|
|
|
AVEX
2361
AEVEX Corp
AVEX
$1B
| $23.4M | ﹤0.01% |
+1,119,755
| New | +$29.1M |
2026 Q2
0 quarters
|
|
2362
Forum Energy Technologies
FET
$954M
| $23.4M | ﹤0.01% |
465,470
-30,243
| -6% | -$1.69M |
2026 Q1
1 quarter
|
|
2363
Myriad Genetics
MYGN
$434M
| $23.3M | ﹤0.01% |
4,081,376
+156,851
| +4% | +$712K |
2026 Q1
1 quarter
|
|
2364
HBT Financial
HBT
$1.32B
| $23.2M | ﹤0.01% |
726,752
+206,638
| +40% | +$5.94M |
2026 Q1
1 quarter
|
|
2365
Ennis
EBF
$571M
| $23.1M | ﹤0.01% |
1,089,124
+3,313
| +0.3% | +$68.9K |
2026 Q1
1 quarter
|
|
|
NXDR
2366
Nextdoor Holdings
NXDR
$944M
| $23.1M | ﹤0.01% |
10,168,061
+494,582
| +5% | +$923K |
2026 Q1
1 quarter
|
|
2367
Sutro Biopharma
STRO
$255M
| $23M | ﹤0.01% |
694,219
-26,223
| -4% | -$818K |
2026 Q1
1 quarter
|
|
2368
Atlanta Braves Holdings Series A
BATRA
$3.7B
| $23M | ﹤0.01% |
409,165
-118,059
| -22% | -$6.29M |
2026 Q1
1 quarter
|
|
2369
Southern California Bancorp
BCAL
$700M
| $23M | ﹤0.01% |
1,104,260
+58,473
| +6% | +$1.11M |
2026 Q1
1 quarter
|
|
2370
Hagerty
HGTY
$1.52B
| $23M | ﹤0.01% |
1,928,492
+60,919
| +3% | +$651K |
2026 Q1
1 quarter
|
|
2371
Ramaco Resources Class A
METC
$516M
| $23M | ﹤0.01% |
1,737,333
-144,589
| -8% | -$2.11M |
2026 Q1
1 quarter
|
|
2372
AdvanSix
ASIX
$438M
| $22.9M | ﹤0.01% |
1,151,355
+27,898
| +2% | +$628K |
2026 Q1
1 quarter
|
|
2373
Credicorp
BAP
$29.6B
| $22.8M | ﹤0.01% |
58,498
+3,292
| +6% | +$1.13M |
2026 Q1
1 quarter
|
|
2374
Design Therapeutics
DSGN
$772M
| $22.7M | ﹤0.01% |
1,571,022
+221,172
| +16% | +$2.76M |
2026 Q1
1 quarter
|
|
2375
Rayonier Advanced Materials
RYAM
$482M
| $22.7M | ﹤0.01% |
2,887,509
+92,231
| +3% | +$836K |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Capital Management held 4,163 positions worth $4.68T, up 16% from $4.04T the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 4.2%. Vanguard Capital Management opened 102 new positions and exited 71, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Vanguard Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 20,693,166 shares worth $4.57B.
- Vanguard Capital Management added most to Marvell Technology in Q2 2026, an estimated $3.77B increase.
- Vanguard Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $4.59B.
- Vanguard Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.69B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.68T portfolio in Q2 2026.
- Vanguard Capital Management opened 102 new positions and closed 71 in Q2 2026.
- Vanguard Capital Management's portfolio value rose 16% quarter-over-quarter to $4.68T.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.